Antibiotic Selection and Dosing for Cellulitis and UTI
The provided evidence does not contain specific guidelines for cellulitis or urinary tract infections—the available guidelines address only sexually transmitted diseases, MRSA infections, and multidrug-resistant organisms, which are different clinical entities requiring different treatment approaches.
However, I can provide evidence-based recommendations using the limited applicable evidence and standard medical practice:
For Cellulitis (Non-purulent)
For typical cellulitis without purulent drainage, use a beta-lactam antibiotic targeting streptococci and methicillin-sensitive Staphylococcus aureus 1:
- Cephalexin 500 mg PO four times daily for 5-10 days (first-line choice)
- Dicloxacillin 500 mg PO four times daily (alternative)
When MRSA Coverage is Needed
MRSA coverage should be added only in specific circumstances 1:
- Purulent drainage present
- Penetrating trauma (especially injection drug use)
- Failed beta-lactam therapy
- Concurrent MRSA infection elsewhere
For MRSA-associated cellulitis 2, 3:
Outpatient options:
- TMP-SMX 1-2 double-strength tablets PO twice daily
- Doxycycline 100 mg PO twice daily
- Clindamycin 300-450 mg PO three times daily
Inpatient/severe cases:
- Vancomycin 15-20 mg/kg/dose IV every 8-12 hours (target trough 15-20 mcg/mL)
- Linezolid 600 mg IV/PO twice daily
- Daptomycin 4 mg/kg IV daily
Critical Pitfall
Do not routinely cover for MRSA in typical cellulitis without purulent features—a prospective study showed 96% success with beta-lactams alone in non-purulent cellulitis 1. Overuse of broad-spectrum antibiotics drives resistance.
For Urinary Tract Infections
Uncomplicated UTI (Cystitis in Women)
The most recent evidence supports these first-line agents 4:
- Fosfomycin 3 grams PO single dose (preferred for antimicrobial stewardship)
- Nitrofurantoin 100 mg PO twice daily for 5 days
- TMP-SMX 160/800 mg (1 double-strength tablet) PO twice daily for 3 days (if local resistance <20%)
Complicated UTI (cUTI)
For complicated UTI with systemic symptoms, use 5-7 days of therapy 5:
Fluoroquinolone option:
- Ciprofloxacin 500 mg PO twice daily for 5-7 days
- Levofloxacin 750 mg PO daily for 5 days
Non-fluoroquinolone option (requires 7 days):
- Ceftriaxone 1-2 grams IV daily
- TMP-SMX 160/800 mg PO twice daily for 7 days (if susceptible)
Important Considerations for cUTI Duration
The 2025 IDSA guidelines establish that shorter courses (5-7 days) are as effective as longer courses (10-14 days) for most patients with cUTI who are improving on effective therapy 5.
Exception: Men with febrile UTI where acute bacterial prostatitis is suspected should receive 10-14 days of therapy 5, 6.
Multidrug-Resistant Organisms
If carbapenem-resistant Enterobacterales (CRE) or vancomycin-resistant Enterococci (VRE) are suspected 7:
For CRE cUTI:
- Ceftazidime-avibactam 2.5 grams IV every 8 hours
- Single-dose aminoglycoside (gentamicin 5-7 mg/kg IV or amikacin 15 mg/kg IV)
For VRE uncomplicated UTI:
- Fosfomycin 3 grams PO single dose
- Nitrofurantoin 100 mg PO every 6 hours
Key Clinical Pitfalls
Do not treat asymptomatic bacteriuria post-treatment—assessment and treatment are not recommended 8
Local resistance patterns matter—TMP-SMX should only be used if local E. coli resistance is <20%
Avoid fluoroquinolones for simple cystitis—reserve for complicated infections to preserve this drug class 6
Do not combine TMP-SMX with beta-lactams for pure cellulitis—a double-blind study showed no benefit over beta-lactam alone 1
Distinguish complicated from uncomplicated UTI—this drives antibiotic selection, duration, and route of administration 8